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Objective. To determine the extent to which pediatrics is taught at US doctor of pharmacy (PharmD)
programs and to characterize what is being taught and how.
Methods. A 40-question online survey instrument was sent to accredited and candidate-status US
PharmD programs.
Results.Of 86 participating programs (67.2% response rate), 81 (94.2%) indicated that pediatric topics
were included in their required classroom curricula (mean, 21.9 contact hours). A pediatric elective
course was offered by 61.0% of programs (mean, 25.9 contact hours). Advanced pharmacy practice
experiences (APPEs) in pediatrics were offered by 97.4% of programs, with an average of 27 students
per program completing this practice experience annually.
Conclusions. Almost all responding programs incorporated pediatrics in their required curricula.
Pediatric elective courses provided an adequate mean number of contact hours, but 39.0% of programs
did not offer an elective course. One-fifth of students completed a pediatric APPE prior to graduation.
Continued expansion of pediatric-focused classroom and experiential curricula across US PharmD
programs is recommended.
Keywords: pharmacy education, pediatrics, curriculum
INTRODUCTION
The Accreditation Council for Pharmacy Education
(ACPE) Accreditation Standards and Guidelines identify
the training of pharmacy students to provide care for spe-
cial populations (eg, pediatric patients) as 1 of the science
foundation elements essential to the development of phar-
macists.1 They recommend that doctor of pharmacy de-
gree (PharmD) programs integrate pathophysiologic and
pharmacotherapy alterations, dosage calculation and ad-
justments, and drug monitoring for positive and negative
outcomes for special populations into their curricula.1
However, the ACPE guidelines do not specifically address
the extent to which pediatrics should be incorporated into
the curricula nor do they address which specific pediatric
topics should be covered.
The Pediatric Practice and Research Network (PRN)
of the American College of Clinical Pharmacy (ACCP)
published recommendations in 2005 that outlined curric-
ular standards for pediatrics in pharmacy programs across
the United States (US) and Canada.2 This group recom-
mended that the curricula at all pharmacy programs
should include a minimum of 25 hours of classroom in-
struction in pediatrics, specifying that pediatric topics be
introduced during the first year of the PharmD program.
This group also recommended that an elective course in
pediatrics consisting of 16 to 32 contact hours should be
available to students and that all pharmacy schools offer
students at least 1 practice experience in pediatrics.2
Whether pharmacy colleges and schools across the coun-
try have abided by these recommendations is unknown.
The purpose of this study was to determine the extent to
which pediatrics is taught at US PharmD programs and to
characterize what content is being taught and how it is
being taught.
METHODS
One hundred twenty-eight candidate-status and
accredited PharmD programs in the United States and
its territories were identified using the ACPE website.3
Programs having precandidate status during the 2012-
2013 academic year and programs that were located out-
side the United States or Puerto Rico were excluded.
A 40-question survey instrument was designed to collect
information fromrespondingprogramsabout their pediatric
Corresponding Author: William Allan Prescott, Jr.,
PharmD, University at Buffalo School of Pharmacy and
Pharmaceutical Sciences, 218 Kapoor Hall, Buffalo, NY
14214. Tel: 716-645-4780. Fax: 716-829-6093. E-mail:
prescott@buffalo.edu
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curricula. Skip logic, which directs the respondent
through different paths in the survey based on their re-
sponses, was integrated to minimize survey fatigue. There-
fore, the exact number of questions requiring an answer
depended upon survey instrument responses. Demographic
data for the respondingprograms thatwerenot readily avail-
able on the American Association of Colleges of Pharmacy
(AACP) or ACPE websites were requested from the pro-
grams (eg, number of students enrolled and pediatric-
focused faculty members). PharmD program locations
were retrieved from the ACPE website.3 The current ac-
creditation status and the years that each program had
been in existence were requested from the programs and
verified using data available on the ACPE website. Pri-
vate and public institution data were retrieved from the
Pharmacy College Application System website and in-
dividual PharmD program websites.4 If the curriculum of
a responding program included content in pediatrics, in-
formation about the extent and type of required and elective
classroom coursework, experiential teaching related to pe-
diatrics, and instructional methodologies used to teach pe-
diatrics were requested. To pretest the survey instrument,
the clarity of question compositionwas validated by a phar-
macy faculty member not directly involved in this study.
During the validation process, this individual was asked to
provide feedback regarding whether the survey instrument
adequately addressed the study’s primary objective (ie, de-
termining the extent to which pediatrics is taught in the
curricula of US PharmD programs) and the secondary ob-
jectives (ie, characterizing what pediatric content is being
taught and how it is being taught). The survey instrument
was revisedbasedon the facultymember’swritten feedback.
An electronic hyperlink to the survey instrument was
e-mailed to faculty members at all 128 ACPE-accredited
and candidate-status PharmD programs in the US and its
territories. SurveyMonkey (SurveyMonkey, Inc, Port-
land, OR) was used to collect survey responses. The sur-
vey instrument was initially distributed on May 7, 2013,
using the curriculum special-interest group e-mail list
(purchased from AACP) and a reminder was e-mailed to
all programs on this list 2 weeks later (May 21, 2013). To
enhance the survey response rate, pharmacy college and
school websites for programs that had not yet responded
were reviewed to identify associate deans of academics as
well as faculty members specializing in pediatrics. An
e-mail was distributed to this targeted list on June 4,
2013, and a reminder e-mail was sent 2 weeks later (June
18, 2013) to programs that still had not responded. The
survey was open for 8 weeks, closing on July 2, 2013.
Survey responses were downloaded into Microsoft
Excel. In the eventmultiple responseswere received from
the same program, data were combined to account for all
responses. However, when conflicting answers were cho-
sen for certain questions, such as those asking for a yes or
no response, data could not be combined. To account for
these isolated instances, an order of preference was pre-
assigned, based on the responding individual’s position,
with highest preference given to faculty members consid-
ered most likely to have the best understanding of the
classroom and experiential curriculum in pediatrics at
their school, and lowest preference given to those less
likely to understand the intricacies of the curriculum in
pediatrics. Responseswere chosen based on the following
order of preference: faculty members specializing in pe-
diatrics, pharmacy faculty members, department chair,
associate dean, and dean. The distribution of responses
was determined using demographic data, accreditation
status, and type of institution (public vs private). Demo-
graphic data were grouped into 9 divisions based on geo-
graphic location, as defined by the US Bureau of the
Census;NewEngland:Connecticut,Maine,Massachusetts,
NewHampshire, Rhode Island, Vermont; Middle Atlantic:
New Jersey, NewYork, Pennsylvania; East North: Indiana,
Illinois, Michigan, Ohio, Wisconsin; West North: Iowa,
Nebraska, Kansas, North Dakota, Minnesota, South Da-
kota, Missouri; South Atlantic: Delaware, District of
Columbia, Florida, Georgia, Maryland, North Carolina,
South Carolina, Virginia, West Virginia; East South:
Alabama, Kentucky, Mississippi, Tennessee; West South:
Arkansas, Louisiana,Oklahoma, Texas;Mountain:Arizona,
Colorado, Idaho, New Mexico, Montana, Utah, Nevada,
Wyoming; Pacific: Alaska, California, Hawaii, Oregon,
Washington.5 Survey responses were analyzed using
Microsoft Excel. Frequency and descriptive statistics were
used to characterize the extent to which pediatrics was
taught, what pediatric content was being taught, and how
it was being taught at US PharmD programs. This study
was deemed exempt from institutional review board (IRB)
approval by the University at Buffalo Social and Behav-
ioral Sciences IRB on April 13, 2013.
RESULTS
Eighty-six of 128 US PharmD programs responded
to the survey, yielding a survey response rate of 67.2%.
Multiple responses were received from22 programs.More
than 90% of responding programs were ACPE-accredited
during the 2012-2013 academic year (Table 1). The survey
response rates for accredited and candidate-status pro-
grams were 68% (78/114) and 57% (8/14), respectively.
The percentage of responding programs thatwere public or
private and the geographic distribution of the programs
were similar to those of the sample size as a whole (data
not shown). The mean class size for the responding
programs was 126661 students, with approximately
American Journal of Pharmaceutical Education 2014; 78 (3) Article 51.
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three-fourths of responding programs enrolling 51-150
students. The mean full-time, part-time, and adjunct fac-
ulty specializing in pediatrics was 1.9, 0.4, and 2.1 per
program, respectively. However, only 75.3% (64/85) of
the programs employed a full-time faculty member spe-
cializing in pediatric pharmacy.
Eighty-one of the 86 responding programs (94.2%)
indicated that pediatrics was included in their required
curriculum.Themean andmedian number of contact hours
were 21.9622.9 hours and 16 hours, respectively (range,
1 to 153 hours). Seventy-two programs specified the num-
ber of contact hours; 19 (26.4%) programs dedicated more
than 25 hours to pediatrics in the core curriculum, whereas
53 (73.6%) programs did not. Pediatrics was introduced
during the first, second, and third year of the PharmD pro-
gramat 42.5%, 39.7%, and 16.4%of responding programs,
respectively. However, most of the topics were taught dur-
ing the third year (60.3%). One respondent indicated that
their program was a 3-year accelerated program that
introduced and taught the majority of topics during the
third year. Approximately half of responding programs
taught the majority of topics as standalone classes, whereas
half did so as subsections of adult topics. Of the 41 pro-
grams that indicated plans for curricular revision in the next
5 years, 29.3% planned to increase the number of contact
hours dedicated to pediatrics. Of the 5 programs that did not
include pediatrics in their required curriculum, 3 indicated
plans to do so.
Table 2 lists the topics covered in the required cur-
ricula of responding programs. More than 80% of pro-
grams indicated teaching the effects of renal and hepatic
maturation on drugmetabolism and elimination, pediatric
infectious diseases, immunization, selection of drug doses
and dosing forms for pediatric patients, and assessment of
renal function in pediatric patients. The types of instruction
most commonly employed to teach pediatric topics in the
required curricula were lecture (91.8%) and case-based
instruction/learning (87.7%) (Table 3). When programs
were asked to choose the instructional method used most
commonly within their required course(s), lecture was
cited by 59.2% of programs, whereas case-based instruc-
tion/learning was cited by only 18.3%.
Forty-seven of the 77 responding programs (61.0%)
indicated that they offered a standalone pediatric elective
course. The mean and median number of contact hours
dedicated to pediatric elective courses were 25.9613.3
hours and 29 hours, respectively (range, 2 to 60 hours).
Thirty-five (74.5%) of the programs dedicated more than
16 contact hours to the elective course,whereas 12 (25.5%)
did not meet this threshold. The pediatric elective course
was offered during the third, second, and first years of the
PharmD program at 91.5%, 29.8%, and 2.1% of programs,
respectively (1 program offered the elective course during
the summer preceding the third year, which was included
as a third-year course for the purpose of this study’s survey
instrument). Eighty-one percent of programs limited the
elective course to students in a single year of the program,
whereas 19% offered it to students in more than 1 year of
the PharmD program. Thirty-four (72.3%) programs en-
rolled 11-30 students in the elective course. Of the 30
programs that did not offer an elective course, 12 (40%)
indicated plans to do so. Seventeen of the 30 programs
(56.7%) that reported not offering a standalone elective
course did cover pediatric topics in other elective courses.
Table 4 lists the topics covered in the elective cur-
ricula of responding programs. Topics varied greatly,
with pediatric infectious diseases and neonatology being
the only topics included by at least 80% of programs. The
types of instruction most commonly used to teach pedi-
atrics in the elective curricula were lecture (75.6%) and
case-based instruction/learning (71.1%) (Table 3). When
Table 1. Demographics of United States Doctor of Pharmacy
Programs Participating in the Survey About Pediatric
Education in Pharmacy (N 5 86)
Demographic No. (%)
Accreditation status
Candidate 8 (9.3)
Accredited 78 (90.7)
Public/private
Public 44 (51.2)
Private 42 (48.8)
Regional distribution
East North 13 (15.1)
East South 8 (9.3)
Middle Atlantic 12 (14.0)
Mountain 6 (7.0)
New England 6 (7.0)
Pacific 9 (10.5)
South Atlantic 14 (16.3)
West North 9 (10.5)
West South 8 (9.3)
Othera 1 (1.2)
No. years in existence
# 5 years 9 (10.5)
6-10 years 17 (19.8)
11-20 years 9 (10.5)
.20 years 51 (59.3)
No. students per graduating class
,50 2 (2.3)
51-100 36 (41.9)
101-150 28 (32.6)
151-200 11 (12.8)
.200 9 (10.5)
aSchool located in Puerto Rico.
American Journal of Pharmaceutical Education 2014; 78 (3) Article 51.
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Table 2. Pediatric Topics Taught in Required Curricula at United States PharmD Programs (n573)
Topics Programs, No. (%)
Recommended Topicsa
Effects of renal and hepatic maturation on drug metabolism and elimination 64 (87.7)
Pediatric Infectious Diseases 63 (86.3)
Acute otitis media 63 (86.3)
Upper respiratory tract infection 47 (64.4)
Meningitis 44 (60.3)
Lower respiratory tract infection (bronchiolitis) 35 (47.9)
Lower respiratory tract infection (community acquired pneumonia) 35 (47.9)
Sepsis 28 (38.4)
Urinary tract infection 22 (30.1)
Immunizations 63 (86.3)
Selection of drug doses and dosing forms for pediatric patients 62 (84.9)
Assessment of renal function in pediatric patients 60 (82.2)
Appropriate sources of drug information for pediatric patients and policies for off-label drug use 56 (76.7)
Therapeutic drug monitoring (eg, of aminoglycosides, vancomycin, antiepileptics) 55 (75.3)
Strategies to reduce medication errors in pediatric patients 51 (69.9)
Fluid and electrolyte therapy (eg, for dehydration) 47 (64.4)
Growth and development (eg, embryonic and fetal development, failure to thrive, growth charts, obesity) 47 (64.4)
Safety issues about neonatal exposure to excipients in pharmaceutical products 46 (63.0)
Nutrition (eg, with infant formulas, vitamins, supplements) 43 (58.9)
Effective communication techniques for parents and children 30 (41.1)
Pediatric physical assessment 27 (37.0)
Clinical toxicology 21 (28.8)
Strongly Encouraged Topicsb
Drugs commonly used in pregnancy and lactation 54 (74.0)
Cystic fibrosis 53 (72.6)
Psychiatry (eg, attention deficit disorder) 51 (69.9)
Neonatology (eg, apnea of prematurity, chronic lung disease, sepsis,
respiratory distress syndrome, nutrition, enteral drug absorption)
29 (39.7)
Neurology (eg, epilepsy, migraine, cerebral palsy) 26 (35.6)
Hematology (eg, thalassemia, sickle cell disease) 25 (34.2)
Oncology 24 (32.9)
Gastroenterology (eg, gastroesophageal reflux, short-gut syndrome) 20 (27.4)
Immunology (eg, juvenile rheumatoid arthritis, lupus, food allergies, anaphylaxis) 17 (23.3)
Human immunodeficiency virus and acquired immunodeficiency syndrome 16 (21.9)
Pediatric cardiology (eg, structural heart defects, cardiomyopathy, cardiac arrhythmias) 16 (21.9)
Substance abuse in adolescence 11 (15.1)
Nephrology (eg, hypertension, nephrotic syndrome, vesicoureteral reflux) 9 (12.3)
Additional Topicsc
Pulmonology (eg, asthma) 56 (76.7)
Fever 53 (72.6)
Pain management 37 (50.7)
Endocrinology (eg, diabetes) 31 (42.5)
Other 2 (2.7)d
aAmerican College of Clinical Pharmacy Pediatric Practice and Research Network (ACCP Pediatric PRN) 2005 recommended pediatric subject
areas.
bACCP Pediatric PRN 2005 strongly encouraged pediatric subject areas.
cpediatric subject areas omitted from the ACCP Pediatric PRN 2005 opinion paper.
deczema (n51), ketogenic diet (n51).
American Journal of Pharmaceutical Education 2014; 78 (3) Article 51.
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asked to choose the instructional method used most com-
monly within their elective course(s), 36.4% of the pro-
grams cited lecture.
Forty-one of the 77 responding programs (53.2%)
offered an introductory pharmacy practice experience
(IPPE) in pediatrics, 1 of which required this experience.
Of the 36 programs that did not offer an IPPE, 10 (27.8%)
indicated plans to develop one. Only 5 of the 21 programs
that did not have a full-time faculty member specializing
in pediatrics offered an IPPE. Introductory pharmacy
practice experienceswere offered during the first, second,
and third years of the PharmD program in 39.5%, 63.2%,
and 65.8% of programs, respectively. The most common
IPPE offered by responding programs was inpatient gen-
eral pediatrics (73.2%) (Table 5). Seventy-four of the 76
responding programs (97.4%) offered an APPE in pedi-
atrics, 3 ofwhich required this experience. Themean class
size for these 3 programs was 138 students. One of these
programs had 6 full-time and 10 adjunct faculty members
specializing in pediatrics, whereas the other 2 reported
only 1 full-time faculty member. Of the 2 programs that
did not offer anAPPE in pediatrics, 1 indicated plans to do
so.Of the 21 programswithout a full-time facultymember
specializing in pediatrics, 16 offered a pediatric APPE.
Among all programs (including those that required a pe-
diatric APPE), a mean of 22 APPE modules were offered
(range, 1 to 164 modules), with a mean of 27 students
completing a practice experience annually (range, 2 to
164 students). The APPE length ranged from 4 to 6weeks
and was evenly distributed among 4-, 5-, and 6-week
modules. Programs indicated that students spent an aver-
age of 39.368.3 hours per week dedicated to this practice
experience (range, 5 to 60 hours). As with IPPE, inpatient
general pediatrics was the most common APPE overall
(Table 5).
DISCUSSION
The ACPE accreditation guidelines identify the train-
ing of pharmacy students to provide care for pediatric pa-
tients as one of the science foundation elements they
believe to be essential to the development of pharmacists.1
The results of a 1997 survey designed to characterize the
classroom and experiential content in pediatrics of US col-
leges and schools of pharmacy found that only 37 (67%)
programs included pediatrics in their curriculum.6 The
mean amount of time allocated to pediatric topics in the
curricula at these colleges and schools was 16.7611.6
hours. Eighteen percent of programs indicated that they
offered a separate elective, whereas an additional 36%of
programs reported that elective coursework in pediatrics
was offeredwithin nonpediatric-focused electives. Ninety-
three percent of programs offered an APPE in pediatrics,
but only 40% of enrolled students had the opportunity to
complete this type of experience prior to graduation.
Nearly a decade after this study was conducted, the Pedi-
atric PRN of the ACCP published an opinion paper recom-
mending that the PharmD curricula should foster a core of
knowledge, skills, abilities, attitudes, and values necessary
for pharmacists to become well-rounded general practi-
tioners who can provide care to a wide variety of patients,
including infants and children.2 This group provided spe-
cific curricular recommendations intended to assist schools
in accomplishing this goal. However, current data describ-
ing towhat extent pediatrics is being taught,what topics are
being taught, and how pediatrics is being taught across US
PharmD programs have been lacking, and, thus, how pro-
gram curricula have changed since publication of the
ACCP recommendations is unknown. Our study aimed to
answer these questions in order to provide guidance to
pharmacy programs for self-assessing and, if needed, for
modifying their curriculum in pediatrics.
Our study found that nearly all of the responding
PharmD programs (94.2%) included pediatrics in their
required classroom curriculum, despite 25% of programs
Table 3. Types of Pediatric Instruction Used by United States
Doctor of Pharmacy Programs
Instructional Method
Programs,
No. (%)
Required curriculum (n573)
Lecture 67 (91.8)
Case-based instruction/learning 64 (87.7)
Discussion, large group (.12 students) 35 (47.9)
Discussion, small group (#12 students) 26 (35.6)
Laboratory 26 (35.6)
Team-based learning 25 (34.2)
Problem-based learning 22 (30.1)
Independent learning 20 (27.4)
Self-directed learning 13 (17.8)
Journal club 9 (12.3)
Simulation 7 (9.6)
Workshop 7 (9.6)
Elective curriculum (n545)
Lecture 34 (75.6)
Case-based instruction/learning 32 (71.1)
Discussion, small group (#12 students) 25 (55.6)
Discussion, large group (.12 students) 19 (42.2)
Independent learning 18 (40.0)
Problem-based learning 16 (35.6)
Journal club 10 (22.2)
Self-directed learning 10 (22.2)
Team-based learning 10 (22.2)
Simulation 4 (8.9)
Laboratory 2 (4.4)
Workshop 2 (4.4)
American Journal of Pharmaceutical Education 2014; 78 (3) Article 51.
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not employing a full-time faculty member specializing
in pediatric pharmacy practice. This finding indicates
a considerable increase compared with the 1997 survey,
which estimated that only two-thirds of PharmD pro-
grams taught pediatrics in their required classroom cur-
riculum.6 The vast majority of programs, therefore,
appear tobe in compliancewithACPEaccreditationguide-
lines that recommend pharmacy students be trained to pro-
vide care for special populations, including pediatrics.1
Our study also revealed that the time dedicated to pedi-
atrics in the required curriculum has increased by 31%
since 1997, with PharmD programs now providing
an average of 22 contact hours of pediatric pharmacy
education.6 Despite this increase, the majority of
PharmD programs included in this survey still do not
meet the 25 contact-hour expectation outlined in the
ACCP Pediatric PRN opinion paper.2 However, given
that pediatric topics may be dispersed among courses
and lecture classes, making it difficult to calculate/report
the precise number of contact hours, these data are only
approximations. Further, the contact hour recommenda-
tion published by ACCP should be viewed only as a guide
for PharmD programs to use when designing/modifying
their pediatric curricula.
The ACCP Pediatric PRN recommended that all
PharmD programs offer an elective course in pediatrics.
In line with this recommendation, a joint opinion paper
from the ACCP Pediatric PRN and Pediatric Pharmacy
AdvocacyGroup (PPAG) published in 2013 indicated the
importance of offering an elective course in pediatric
pharmacotherapy for students interested in pediatrics in
order to help develop clinical pharmacists in this specialty
area of practice.7 Our study found that nearly two-thirds
of responding programs offered a standalone elective
course in pediatrics, representing a 43% increase since
1997.6 Three-quarters of these programs met the goal of
16-32 hours recommended in the ACCP Pediatric PRN
opinion paper,2 but the portion of programs meeting this
recommendation may actually be higher, based on the
following: 4 programs appear to have misinterpreted the
survey instrument question as asking for credit hours
rather than contact hours (2 indicated that their elective
course consisted of only 2 contact hours and 2 indicated
that their elective course consisted of only 3 contact
hours). Among programs that did not offer a standalone
elective course, more than half taught pediatrics in other
elective courses, the extent of which is unknown. Of the
16 programs that did not have a full-time faculty member
specializing in pediatrics, 9 offered a standalone elective
course in pediatrics, demonstrating that programs can find
a way to offer an elective course even without a full-time
faculty member specializing in pediatrics.T
ab
le
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The ACCP Pediatric PRN opinion paper recommen-
ded 15 topics in pediatrics. After grouping the pediatric
infectious disease topics assessed in our survey into a sin-
gle topic, only 3 of the ACCP Pediatric PRN recommen-
ded pediatric topics were not included in the majority of
PharmD program required curricula: clinical toxicology;
pediatric physical assessment; and effective communica-
tion for parents and children.2 While the topics taught by
the majority of programs have not changed much since
1997, our survey found that there has been an increase in
the number of PharmD programs covering the following
ACCP Pediatric PRN recommended topics: growth and
development; nutrition; fluid and electrolyte therapy; se-
lection of drug doses and dosing forms for pediatric pa-
tients; and, appropriate sources of drug information for
pediatric patients and policies for off-label drug use.2,6
The quality of instruction should also be considered of
utmost importance. In our study, we observed that both
lecture and case-based instruction/learning were com-
monly used to teach pediatrics. However, lecture was
identified as the most commonly used method, despite
evidence suggesting that active-learning strategies, such
as case-based learning, may be a more effective way to
teach pharmacy students.8
Experiential education is a valuable aspect of phar-
macy education. TheACCPPediatric PRN recommended
that all students should have the opportunity to complete
at least 1 practice experience in a pediatric setting.2 Corre-
spondingly, the ACCP Pediatric PRN and PPAG recom-
mended that all core topics be reinforced during practice
experiences in pediatrics.7 The results of our survey indi-
cate an increase in the percentage of programs offering at
least 1 APPE specializing in pediatrics from 93% to 97%
since 1997.6 Inpatient APPEs were found to be the pre-
dominant training experience for pediatrics, similar towhat
was reported in 1997. Ambulatory care APPEs remain
essentially untapped, with only one-fourth of PharmD pro-
grams offering an experience in this setting.As the focus of
healthcare shifts from the inpatient setting to the outpatient
setting, programs may need to consider expanding the
training of students in pediatric ambulatory care. Themean
number of students completing an APPE in pediatrics has
almost doubled since 1997, increasing from12 students per
program in 1997 to 23 students in 2013.6 However, the
mean class size in our study population of 126 students
indicates that less than 20%of students engage in anAPPE
in pediatrics prior to graduation, which is half of what was
reported in 1997.6 Therefore, colleges and schools must
explore avenues to expand experiential training opportuni-
ties in pediatrics in order to meet the ACCP Pediatric PRN
recommendations.
A limitation to our studywas the survey response rate
of 67.2%. Although it exceeds 60% and is, therefore, ac-
ceptable, the response rate did not attain our goal of 80%.9
Therefore, the data presented herein cannot be considered
representative of all US PharmD programs. However, the
distributionof responses andnonresponses fromaccredited
and candidate-status programs, public and private institu-
tions, and geographic region, is similar to the demograph-
ics of the sample size as a whole, which should have
minimized the risk for nonresponse bias in this study.
CONCLUSION
Almost all of the responding US PharmD programs
included pediatrics in their required classroom curricula.
Themean number of contact hours dedicated to pediatrics
was approximately 22 hours, with the majority of topics
being covered during the third year of the PharmD pro-
gram. The topics covered in the required curricula some-
what alignedwithACCPPediatric PRNrecommendations.
Table 5. Pediatric Experiential Education Offered by United States Doctor of Pharmacy Programs
IPPEs Programs (n=41), No. (%) APPEs Programs (n=72), No. (%)
Inpatient general pediatrics 30 (73.2) Inpatient general pediatrics 63 (87.5)
Distributional 16 (39.0) Neonatal intensive care 48 (66.7)
Ambulatory general pediatrics 10 (24.4) Pediatric intensive care 48 (66.7)
Pediatric hematology/oncology 6 (14.6) Pediatric hematology/oncology 29 (40.3)
Neonatal intensive care 5 (12.2) Ambulatory general pediatrics 19 (26.4)
Pediatric intensive care 5 (12.2) Distributional 17 (23.6)
Pediatric infectious diseases 2 (4.9) Pediatric infectious diseases 11 (15.3)
Other 6 (14.6)a Other 10 (13.9)b
Abbreviations: IPPEs5introductory pharmacy practice experiences; APPEs5advanced pharmacy practice experiences.
aAdolescent medicine (n51), immunization clinics (n51), student-run free medical clinic (n51), service learning (n52), asthma and allergy
ambulatory care (n51), pediatric nephrology and solid organ transplantation (n51).
bManagement (n51), medication safety (n51), emergency department (n51), pediatric nephrology and solid organ transplantation (n51),
pediatric pulmonology (n51), asthma and allergy ambulatory care (n51), pediatric complicated care (n51), pediatric pulmonology clinic (n51),
pediatric surgery (n51), rehabilitation (n51), adolescent medicine (n51), special needs patients (n51).
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Slightly more than half of responding PharmD programs
offered a standalone elective course in pediatrics, with the
mean number of contact hours meeting ACCP recommen-
dations. The majority of responding PharmD programs
offered an IPPE and almost all offered an APPE in pediat-
rics. However, the quantity of available APPEs appears to
be inadequate to meet the needs of all graduating students.
Continued expansion of pediatric-focused classroom and
experiential curricula across US PharmD programs is
therefore recommended to ensure that the next generation
of pharmacists is able to effectively care for this special
population.
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